type 2 diabetes
Conditions
Interventions
After inclusion a bloodtest will be performed at T=0 months and T= 12 months,
for the measurement of the serum antihypertensive level, to objectify
medication non-adherence. In 2 trial arms, analysi
Sponsors
Leids Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Adults (>18 years) with T2DM AND 2. BP >140/90 mm Hg ( people * 80 years) or > 160/90 mmHg (people > 80 years, based on Dutch guidelines), measured during the last-check up at the general practice/ endocrinologist using a 30-minute bloodpressure monitor. AND 3. use of three adequately dosed antihypertensive medications, including a diuretic during at least the past 3 months
Exclusion criteria
Exclusion criteria: 1. type 1 diabetes; 2. eGFR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in blood pressure between groups after 12 months. The effect of a measurement of the antihypertensive serum level to objectify adherence to medication on the blood pressure after 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| What is the effect of a theory driven nurse-led patient-centred approach, including a decision aid for hypertensive, non-adherent individuals with T2DM and uncontrolled BP on: 1. Body weight 2. Number of smokers that quit smoking 3. adherence to physical exercise guidelines 4. adherence to nutrition guidelines (salt, vegetable, alcohol intake) 5. BP and the proportion of people that achieve their personalised treatment target based on SDM; 6. Antihypertensive medication adherence; 7. Reasons for non-adherence 8. Prescribed medication; 9. Beliefs about medication and Illness perceptions; 10. Health related quality of life; 11. Health related costs (cost-effectiveness). 12. Number of referrals to secondary care | — |
Countries
Netherlands
Outcome results
None listed